Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases

Background: To analyze the outcomes of patients with brain metastases (BM) from non-small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic radiotherapy (SRT) and to study the impact of the sequence between the two modalities. Methods: The authors reviewed the records of 51 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Porte, Judith, Saint-Martin, Caroline, Frederic-Moreau, Thomas, Massiani, Marie-Ange, Bozec, Laurence, Cao, Kim, Verrelle, Pierre, Otz, Joelle, Jadaud, Eric, Minsat, Mathieu, Langer, Adriana, Girard, Nicolas, Créhange, Gilles, Beddok, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496146/
https://www.ncbi.nlm.nih.gov/pubmed/36140349
http://dx.doi.org/10.3390/biomedicines10092249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496146/
https://www.ncbi.nlm.nih.gov/pubmed/36140349
http://dx.doi.org/10.3390/biomedicines10092249

Ejemplares similares